- US100 slips slightly at the U.S. market open
- Tesla and IBM shares fall after earnings, while Dow Inc. and Honeywell gain.
- Intel is set to report earnings after the U.S. market close.
- US100 slips slightly at the U.S. market open
- Tesla and IBM shares fall after earnings, while Dow Inc. and Honeywell gain.
- Intel is set to report earnings after the U.S. market close.
Wall Street sentiment was mixed at the opening of the U.S. trading session. As of October 17, about 12% of S&P 500 companies had reported third-quarter results. An impressive 86% of them delivered earnings per share (EPS) above analysts’ expectations — a rate higher than the five-year average of 78% and the ten-year average of 75%. However, the average earnings surprise was 5.9%, below the five-year average of 8.4%.The overall earnings growth rate (as of October 17), which includes both reported results and estimates for companies yet to report, currently stands at 8.5%, compared with 7.7% last week and 7.9% at the end of September, according to FactSet Research Systems data. The US100 index is struggling to hold above the 25,000-point level. In the medium term, the benchmark may move back toward testing the 50-day exponential moving average (EMA50, orange line), especially if bulls fail to push it decisively above this psychologically important barrier. Today, after the US session, Intel (INTC.US) will report earnings.
Source: xStation5
Tesla opened the session with a nearly 3% downside gap.
Source: xStation5
Industrial giant Honeywell benefited from a strong quarterly report, with its shares returning above the 200-day exponential moving average (EMA200, red line), attempting to reverse a medium-term downtrend.
Source: xStation5
Company News
-
Tesla (TSLA.US) fell 3.5% after profits plunged despite a record number of vehicle sales.
-
Dow Inc. (DOW.US) rose 6% after the U.S. chemical company beat third-quarter operating EBITDA estimates.
-
Honeywell (HON.US) gained 4% following better-than-expected adjusted earnings per share (EPS).
-
IBM (IBM.US) declined 7% as revenue in key software segments — including the Red Hat unit — fell short of expectations.
-
Las Vegas Sands (LVS.US) advanced 5% after reporting third-quarter EPS above analyst forecasts.
-
LendingClub (LC.US) jumped 11% after providing upbeat Q4 loan origination guidance; JPMorgan upgraded the stock to overweight.
-
Moderna (MRNA.US) dropped 4% after its cytomegalovirus vaccine failed to meet its endpoint in a late-stage trial.
-
Molina Healthcare (MOH.US) plunged 18% after cutting full-year adjusted profit guidance due to higher medical costs across all business segments.
-
T-Mobile US (TMUS.US) slipped 1% following its third-quarter results.
-
Tractor Supply (TSCO.US) fell 3% after narrowing its full-year sales forecast, with the midpoint near the lower end of the previous range.
-
Ribbon Communications (RBBN.US) sank 14% after disappointing Q3 profit and weak Q4 revenue guidance.
-
Ventyx Biosciences (VTYX.US) soared 105% after mid-stage clinical trial results showed significant reductions in cardiovascular risk factors among obese patients.
Nvidia in Consolidation
U.S. stock indices have entered a consolidation phase, perfectly mirrored by Nvidia’s share price, which is currently trading around the 50-day exponential moving average (EMA50, orange line).
Source: xStation5
STMicroelectronics shares down 14% amid mixed future outlook📉
US100 gains 0.5% 📈Kansas City Fed Index above estimates
NATGAS loses after the EIA inventories report
Stock of the Week - Merck & Co Inc (23.10.2025)
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
